Across TCGA pan-cancer cohorts, MIR509-3 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of MIR509-3’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where MIR509-3 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR509-3 is over-expressed in tumor.

KIRC and KIRP are the cancer types where MIR509-3 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR509-3 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	II,III,IV	+0.649	<.001	7	view →
KIRP	All	All	+0.539	.001	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: MIR509-3 RNA expression & survival · all MIR509-3 data types